Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Operating Expenses
$7.10B
TTM · Period ending: · USD
TEVA Operating Expenses
Latest reported$7.10Bperiod ending
Latest reported$7.10Bperiod ending
TEVA TTM Operating Expenses (-$79.30M → $7.10B)
TTM operating expenses
High-resolution chart · PNG
TEVA operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 466,586,000 | |
| 472,748,000 | |
| 436,274,000 | |
| 471,010,000 | |
| 441,899,000 | |
| 393,942,000 | |
| 384,257,000 | |
| 354,500,000 | |
| 355,300,000 | |
| 344,300,000 | |
| 334,900,000 | |
| -737,900,000 | |
| -815,500,000 | |
| -880,600,000 | |
| -943,100,000 | |
| -824,500,000 | |
| -824,500,000 | |
| -824,500,000 | |
| -824,500,000 | |
| -552,500,000 | |
| -552,500,000 | |
| -552,500,000 | |
| -552,500,000 | |
| -481,000,000 | |
| -481,000,000 | |
| -481,000,000 | |
| -481,000,000 | |
| -414,000,000 | |
| -414,000,000 | |
| -414,000,000 | |
| -414,000,000 | |
| -350,700,000 | |
| -350,700,000 | |
| -350,700,000 | |
| -350,700,000 | |
| -275,000,000 | |
| -275,000,000 | |
| -275,000,000 | |
| -275,000,000 | |
| -288,700,000 | |
| -288,700,000 | |
| -288,700,000 | |
| -288,700,000 | |
| -236,900,000 | |
| -236,900,000 | |
| -236,900,000 | |
| -236,900,000 | |
| -188,600,000 | |
| -188,600,000 | |
| -188,600,000 | |
| -188,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -79,300,000 | |
| -79,300,000 | |
| -79,300,000 |